US-CONGRESS HR10372: To amend the Fair Labor Standards Act of 1938 to prohibit employers from paying employees in the garment industry by piece rate, to require manufacturers and contractors in the garment industry to register with the Department of Labor, and for other purposes.
US-CONGRESS HR10372: To amend the Fair Labor Standards Act of 1938 to prohibit employers from paying employees in the garment industry by piece rate, to require manufacturers and contractors in the garment industry to register with the Department of Labor, and for other purposes. — NDA, ANDA update affecting Pharmaceutical Manufacturing (FDA/DEA).
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on September 15, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Pharmaceutical Manufacturing (FDA/DEA) (generic/ANDA manufacturers, API & contract manufacturers) should confirm how it applies to their specific situation before acting. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
US-CONGRESS HR10372: To amend the Fair Labor Standards Act of 1938 to prohibit employers from paying employees in the garment industry by piece rate, to require manufacturers and contractors in the garment industry to register with the Department of Labor, and for other purposes.
Who it affects
Pharmaceutical Manufacturing (FDA/DEA) (generic/ANDA manufacturers, API & contract manufacturers)
What you must do
Read the update and assess whether your current setup needs to change.
Deadline
No fixed deadline was published, but changes like this are often enforced quickly — act promptly.
Source: https://www.congress.gov/bill/119th-congress/house-bill/10372
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- What to Know About the FDA’s Recent Decision to Allow Florida to Import Prescription Drugs from Canada - kff.org
- As Big Pharma and Hospitals Battle Over Drug Discounts, Patients Miss Out on Millions in Benefits - kffhealthnews.org
- Can I Sue Vaccine Manufacturers? - FindLaw
- FDA warning letters highlight CAPA concerns - European Pharmaceutical Review
- RFK Jr.'s Drug Advertising Crackdown Will Face Legal Hurdles (1) - Bloomberg Law News